Literature DB >> 16844693

Exploiting reaction intermediates of the ATPase reaction to elucidate the mechanism of transport by P-glycoprotein (ABCB1).

Zuben E Sauna1, Krishnamachary Nandigama, Suresh V Ambudkar.   

Abstract

The transport cycle of ABC transporters in general and P-glycoprotein in particular has been extensively studied, but the molecular mechanism remains controversial. We identify stable reaction intermediates in the progression of the P-glycoprotein-mediated ATPase reaction equivalent to the enzyme-substrate (E.S, P-glycoprotein.ATP) and enzyme-product (E.P, P-glycoprotein.ADP.P(i)) reaction intermediates. These have been characterized using the photoaffinity analog 8-azido-[alpha-32P]ATP as well as under equilibrium conditions using [alpha-32P]ATP, in which a cross-linking step is not involved. Similar results were obtained when 8-azido-[alpha-32P]ATP or [alpha-32P]ATP was used. The reaction intermediates were characterized based on their kinetic properties and the nature (triphosphate/diphosphate) of the trapped nucleotide. Using this defined framework and the Walker B E556Q/E1201Q mutant that traps nucleotide in the absence of vanadate or beryllium fluoride, the high to low affinity switch in the transport substrate binding site can be attributed to the formation of the E.S reaction intermediate of the ATPase reaction. Importantly, the posthydrolysis E.P state continues to have low affinity for substrate, suggesting that conformational changes that form the E.S complex are coupled to the conformational change at the transport substrate site to do mechanical work. Thus, the formation of E.S reaction intermediate during a single turnover of the catalytic cycle appears to provide the initial power stroke for movement of drug substrate from inner leaflet to outer leaflet of lipid bilayer. This novel approach applies transition state theory to elucidate the mechanism of P-glycoprotein and other ABC transporters and has wider applications in testing cause-effect hypotheses in coupled systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844693     DOI: 10.1074/jbc.M601917200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2).

Authors:  Pavitra Kannan; Sanjay Telu; Suneet Shukla; Suresh V Ambudkar; Victor W Pike; Christer Halldin; Michael M Gottesman; Robert B Innis; Matthew D Hall
Journal:  ACS Chem Neurosci       Date:  2010-10-21       Impact factor: 4.418

2.  Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.

Authors:  Bhagwat Prasad; Raymond Evers; Anshul Gupta; Cornelis E C A Hop; Laurent Salphati; Suneet Shukla; Suresh V Ambudkar; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2013-10-11       Impact factor: 3.922

3.  Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).

Authors:  Biebele Abel; Dilip K Tosh; Stewart R Durell; Megumi Murakami; Shahrooz Vahedi; Kenneth A Jacobson; Suresh V Ambudkar
Journal:  Mol Pharmacol       Date:  2019-05-24       Impact factor: 4.436

4.  Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale.

Authors:  Mavis Jiarong Li; Miklos Guttman; William M Atkins
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

5.  Membrane Assays to Characterize Interaction of Drugs with ABCB1.

Authors:  Zsolt Fekete; Zsuzsanna Rajnai; Tünde Nagy; Katalin Tauberné Jakab; Anita Kurunczi; Katalin Gémes; Krisztina Herédi-Szabó; Ferenc Fülöp; Gábor K Tóth; Maciej Czerwinski; Greg Loewen; Peter Krajcsi
Journal:  J Membr Biol       Date:  2015-04-30       Impact factor: 1.843

6.  The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues.

Authors:  Neeti Ananthaswamy; Robert Rutledge; Zuben E Sauna; Suresh V Ambudkar; Elliot Dine; Emily Nelson; Di Xia; John Golin
Journal:  Biochemistry       Date:  2010-06-01       Impact factor: 3.162

7.  Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus.

Authors:  Ariane Zutz; Jan Hoffmann; Ute A Hellmich; Clemens Glaubitz; Bernd Ludwig; Bernd Brutschy; Robert Tampé
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

8.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

9.  Analyses of conformational states of the transporter associated with antigen processing (TAP) protein in a native cellular membrane environment.

Authors:  Jie Geng; Sivaraj Sivaramakrishnan; Malini Raghavan
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

10.  Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions.

Authors:  Suneet Shukla; Biebele Abel; Eduardo E Chufan; Suresh V Ambudkar
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.